Market revenue in 2023 | USD 35.0 million |
Market revenue in 2030 | USD 52.3 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Biomarker services |
Fastest growing segment | Genetic Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services |
Key market players worldwide | LabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.
Biomarker services was the largest segment with a revenue share of 38.57% in 2023. Horizon Databook has segmented the South Africa central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa has a prominent central lab market in MEA region due to increasing focus on healthcare and rapid technological progress. The country faces several public health challenges related to communicable diseases.
For instance, the country ranks eighth among the 30 countries with high burden of tuberculosis, according to the 2021 WHO Global Tuberculosis Report. It also represents a global epicenter for HIV/AIDS cases with an estimated 7.8 million currently living with HIV in South Africa, as per UNAIDS estimates.
As a result, the country represents a significant patient pool for conducting clinical trials for the evaluation of new product development for these diseases. South Africa has also spearheaded several new clinical developments in the African region and forms a part of several breakthrough clinical trials in the region.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa central lab market , including forecasts for subscribers. This country databook contains high-level insights into South Africa central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account